US · Healthcare · Medical Care Facilities
EPS came in at 0.75 against a street estimate of 0.85 — a miss of 11.8%.
Analysts rate U.S. Physical Therapy, Inc. a buy (6 buy, 1 hold, 0 sell out of 7) with an average price target of $97.00.
| Fund | Stake |
|---|---|
| BlackRock Inc | 15.17% |
| Bahl & Gaynor Inc. | 5.77% |
| Kayne Anderson Rudnick Investment Management LLC | 5.67% |
| Copeland Capital Management, LLC | 5.64% |
| State Street Corp | 4.74% |
| Morgan Stanley - Brokerage Accounts | 4.68% |
| Vanguard Capital Management, LLC | 4.52% |
| Neuberger Berman Group LLC | 4.01% |
| Document | Date |
|---|---|
| Material agreement · Q3 2026 HEADLINE NUMBERS • U.S. Physical Therapy entered into a 45-month, forward-starting interest rate swap on September 22, 2026. • The swap has an initi | 2026-09-28 |
| Board / officer change · Q3 2026 U.S. PHYSICAL THERAPY, INC. - FORM 8-K SUMMARY HEADLINE NUMBERS • Report date: September 15, 2026 • Company: U.S. Physical Therapy, Inc. (ticker: USP | 2026-09-21 |
| Material agreement · Q3 2026 U.S. PHYSICAL THERAPY, INC. – FORM 8-K SUMMARY HEADLINE NUMBERS • New Executive Vice President and Chief Financial Officer appointed effective Septe | 2026-08-14 |
| Reg FD disclosure · Q3 2026 U.S. PHYSICAL THERAPY, INC. (USPH) - FORM 8-K SUMMARY HEADLINE NUMBERS • Company updated investor presentation on August 12, 2026 • Presentation cove | 2026-08-12 |
| Reg FD disclosure · Q3 2026 U.S. PHYSICAL THERAPY, INC. (USPH) - FORM 8-K SUMMARY HEADLINE INFORMATION • Company: U.S. Physical Therapy, Inc., Nevada-incorporated operator of o | 2026-08-10 |
| Quarterly report · Q2 2026 U.S. PHYSICAL THERAPY, INC. - FORM 10-Q SUMMARY For the Quarter Ended June 30, 2026 --- HEADLINE NUMBERS • Net Revenue (6 months): $412.3 million, | 2026-08-07 |
| Results announced · Q3 2026 U.S. PHYSICAL THERAPY, INC. - Q2 2026 RESULTS SUMMARY HEADLINE NUMBERS • Total net revenue $214.1 million in Q2 2026, up 8.5% versus Q2 2025 ($197.3 | 2026-08-06 |
| Quarterly report · Q1 2026 U.S. PHYSICAL THERAPY, INC. - Q1 2026 10-Q SUMMARY HEADLINE NUMBERS • Net Revenue (Q1 2026): $198.3 million, up 7.9% from $183.8 million in Q1 2025 | 2026-05-08 |
Readable in the app.
| Action | Detail | Date |
|---|---|---|
| Dividend | $0.46 / share ex-date Aug 21, 2026 · pay Sep 11, 2026 | 2026-08-21 |
| Dividend | $0.46 / share ex-date May 22, 2026 · pay Jun 12, 2026 | 2026-05-22 |
| Dividend | $0.46 / share ex-date Mar 13, 2026 · pay Apr 10, 2026 | 2026-03-13 |
| Dividend | $0.45 / share ex-date Nov 17, 2025 · pay Dec 12, 2025 | 2025-11-17 |
| Announcement | Date |
|---|---|
| Acquisition of twelve-clinic physical therapy practice for 67% equity stake U.S. Physical Therapy, Inc. (USPH) announced the acquisition of a 12-clinic physical therapy practice effective July 1, 2026. USPH acquired a 67% majority stake while the current owners reta | 2026-07-06 |
| Strategic alliance with NYU Langone Health for 10-year partnership U.S. Physical Therapy, Inc. (USPH) announced a 10-year strategic alliance between its subsidiary Metro Physical Aquatic Therapy and NYU Langone Health, a top-ranked academic medical center. | 2026-02-04 |
| Acquisition of eight-clinic physical therapy management services company U.S. Physical Therapy, Inc. (USPH) announced on January 5, 2026, that it acquired a 50% stake in a physical therapy management services company operating eight clinic locations. The acquired | 2026-01-07 |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for U.S. Physical Therapy, Inc. — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-10-19.